4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzoicacid; 4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoic Acid; 2,4-Diamino-N10- methylpteroic Acid; 4-Amino-4-deoxy-10-methylpteroic Acid; 4-Amino-4-deoxy-N10- methylpteroic Acid; 4-Amino-4-deoxy-N10-methylpteroic Acid; 4-Deoxy-4-amino-N10- methylpteroic Acid; 4-[N-[(2,4-Diaminopyrimido[4,5-b]pyrazin-6-yl)methyl]-Nmethylamino]benzoic Acid; NSC 133723
Methotrexate EP Impurity E is a fully characterized chemical compound used as a reference standard of API Methotrexate. The standard offered is compliant with regulatory guidelines. Methotrexate EP Impurity E is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 19741-14-1
Related products
7-Hydroxy Methotrexate Trisodium Salt
M.F.
M.W. 467.42 3 22.99
CAT# AR-M01605
CAS# 5939-37-7 (free acid and keto form)
